The triple marker screen test is also known as the triple test, multiple marker test, multiple marker screening, and AFP Plus. It analyzes how likely an unborn baby is to have certain genetic disorders. The exam measures the levels of three important substances in the placenta: alpha-fetoprotein (AFP)
